From: Effect of erythropoietin-stimulating agent on uremic inflammation
Variable | Regression coefficient | p value |
---|---|---|
Age | 0.136 | <0.0001 |
Sex (F: 1, M: 2) | 0.004 | 0.897 |
Diabetic nephropathy (no: 1, yes: 2) | −0.008 | 0.8087 |
BMI | 0.052 | 0.1341 |
SBP | −0.087 | 0.0113 |
DBP | −0.068 | 0.0484 |
Duration of nephrologist care | −0.06 | 0.0775 |
CTR | 0.134 | 0.0003 |
Albumin | −0.246 | <0.0001 |
LDL-C | −0.084 | 0.0341 |
HDL-C | −0.153 | <0.0001 |
Hemoglobin | −0.11 | 0.001 |
BUN | 0.011 | 0.743 |
Creatinine | −0.102 | 0.0023 |
eGFR | 0.122 | 0.0002 |
Uric acid | 0.045 | 0.1861 |
Calcium | −0.118 | 0.0004 |
Phosphate | −0.021 | 0.5353 |
Intact-PTH | −0.007 | 0.8627 |
Platelets | 0.061 | 0.068 |
WBC | 0.14 | <0.0001 |
ESA | −0.119 | 0.0005 |
ESA dose | −0.124 | 0.0007 |
ARB | −0.071 | 0.0361 |
ACE-I | −0.052 | 0.1282 |
ARB or ACE-I | −0.075 | 0.0261 |
ARB and ACE-I | −0.059 | 0.0841 |
CCB | −0.1 | 0.0032 |
other anti-HT | −0.065 | 0.0562 |
AST-120 | −0.036 | 0.2943 |
Vitamin D | −0.058 | 0.0863 |
Iron agents | −0.072 | 0.1059 |